Trim Family Proteins In Intracellular Vesicle Trafficking

Kristyn Gumpper,Ki Ho Park,Mingzhai Sun,Peihui Lin,Tao Tan,Miyuki Nishi,Hiroshi Takeshima,Jianjie Ma
DOI: https://doi.org/10.1016/j.bpj.2016.11.1306
IF: 3.4
2017-01-01
Biophysical Journal
Abstract:The tripartite motif (TRIM) family of over 75 different proteins serves regulative roles in many critical aspects of health and disease including wound healing, immunity, secretion and cancer. Our laboratory has previously shown that MG53 (TRIM72) played an essential role in cell membrane repair via trafficking of intracellular vesicles to the injury site. TRIM50 is the closest homologue to MG53, however, it has dissimilar cellular function and tissue localization. The molecular mechanisms that underlie the different functions for MG53 and TRIM50 are unknown. An earlier study from our group showed that TRIM50 is predominantly expressed in the stomach, and is involved in vesicle trafficking during acid secretion in gastric parietal cells. While we know that MG53-mediated vesicle translocation to membrane injury site is driven by a molecular motor named non-muscle myosin II-A (NM2A), the molecular motor that facilitates TRIM50 movement during acid secretion is unknown. In this study, we used intracellular vesicle tracking to examine how TRIM50-associated vesicles move within the cell, distinguishing between diffusive and directional ballistic motions. We found that gastric carcinoma TMK-1 cells transfected with mCherry-TRIM50 display non-diffusive movements, and treatment with microtubule inhibitors such as nocodazole and colchicine abolished the directed motion of the TRIM50-associated vesicles. To determine the differential function and cytoskeletal associations of MG53 and TRIM50, chimeric proteins were constructed and tested for response to cell membrane injury, preferential lipid binding (e.g. phosphatidylserine for MG53 vs phosphatidylinositol for TRIM50), and subcellular localization. Overall, our data suggest that TRIM50-vesicles are associated with dynein, a microtubule-associated molecular motor, to power vesicle trafficking related to acid secretion in gastric parietal cells. Additionally, the critical regions responsible for the differential functions of MG53 and TRIM50 was not found within the divergent C-terminal PRY/SPRY domain, as we had predicted. This study suggests that the N-terminal domain of TRIM family proteins may be responsible for vesicle trafficking, providing a clue on how TRIM family proteins regulate vesicle trafficking and how the genetic ablation of TRIM50 is involved in the gastrointestinal symptoms observed in patients with Williams Syndrome. Additionally, it suggests that we could use a shorter form of MG53 as a new therapeutic agent for muscular dystrophy and cardiovascular disease.
What problem does this paper attempt to address?